GKOS
Price
$75.68
Change
+$1.01 (+1.35%)
Updated
Oct 27 closing price
Capitalization
4.28B
One day until earnings call
Intraday Buy/Sell Signals
PEN
Price
$247.99
Change
-$5.00 (-1.98%)
Updated
Oct 27 closing price
Capitalization
9.87B
8 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

GKOS vs PEN

Header iconGKOS vs PEN Comparison
Open Charts GKOS vs PENBanner chart's image
Glaukos
Price$75.68
Change+$1.01 (+1.35%)
Volume$2.7M
Capitalization4.28B
Penumbra
Price$247.99
Change-$5.00 (-1.98%)
Volume$428.65K
Capitalization9.87B
GKOS vs PEN Comparison Chart in %
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GKOS vs. PEN commentary
Oct 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a Hold and PEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 28, 2025
Stock price -- (GKOS: $75.68 vs. PEN: $247.99)
Brand notoriety: GKOS and PEN are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GKOS: 282% vs. PEN: 105%
Market capitalization -- GKOS: $4.28B vs. PEN: $9.87B
GKOS [@Medical/Nursing Services] is valued at $4.28B. PEN’s [@Medical/Nursing Services] market capitalization is $9.87B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $221.35B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GKOS’s FA Score shows that 0 FA rating(s) are green whilePEN’s FA Score has 0 green FA rating(s).

  • GKOS’s FA Score: 0 green, 5 red.
  • PEN’s FA Score: 0 green, 5 red.
According to our system of comparison, PEN is a better buy in the long-term than GKOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 3 TA indicator(s) are bullish while PEN’s TA Score has 2 bullish TA indicator(s).

  • GKOS’s TA Score: 3 bullish, 4 bearish.
  • PEN’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, GKOS is a better buy in the short-term than PEN.

Price Growth

GKOS (@Medical/Nursing Services) experienced а -4.77% price change this week, while PEN (@Medical/Nursing Services) price change was +0.15% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.30%. For the same industry, the average monthly price growth was +4.72%, and the average quarterly price growth was +15.64%.

Reported Earning Dates

GKOS is expected to report earnings on Oct 29, 2025.

PEN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.30% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PEN($9.87B) has a higher market cap than GKOS($4.28B). PEN YTD gains are higher at: 4.426 vs. GKOS (-49.526). PEN has higher annual earnings (EBITDA): 194M vs. GKOS (-47.8M). PEN has more cash in the bank: 425M vs. GKOS (275M). GKOS has less debt than PEN: GKOS (105M) vs PEN (221M). PEN has higher revenues than GKOS: PEN (1.28B) vs GKOS (433M).
GKOSPENGKOS / PEN
Capitalization4.28B9.87B43%
EBITDA-47.8M194M-25%
Gain YTD-49.5264.426-1,119%
P/E RatioN/A65.61-
Revenue433M1.28B34%
Total Cash275M425M65%
Total Debt105M221M48%
FUNDAMENTALS RATINGS
GKOS vs PEN: Fundamental Ratings
GKOS
PEN
OUTLOOK RATING
1..100
1163
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
7778
SMR RATING
1..100
9563
PRICE GROWTH RATING
1..100
8755
P/E GROWTH RATING
1..100
58100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PEN's Valuation (80) in the Medical Specialties industry is in the same range as GKOS (95). This means that PEN’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (77) in the Medical Specialties industry is in the same range as PEN (78). This means that GKOS’s stock grew similarly to PEN’s over the last 12 months.

PEN's SMR Rating (63) in the Medical Specialties industry is in the same range as GKOS (95). This means that PEN’s stock grew similarly to GKOS’s over the last 12 months.

PEN's Price Growth Rating (55) in the Medical Specialties industry is in the same range as GKOS (87). This means that PEN’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (58) in the Medical Specialties industry is somewhat better than the same rating for PEN (100). This means that GKOS’s stock grew somewhat faster than PEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOSPEN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
65%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 1 day ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FBL44.931.49
+3.43%
GraniteShares 2x Long META Daily ETF
FUSI50.730.02
+0.04%
American Century Multisector Flt Inc ETF
CADJPY109.38N/A
N/A
Canadian Dollar - Japan Yen
RCGE28.04N/A
N/A
RockCreek Global Equality ETF
SPIP26.48-0.01
-0.04%
SPDR® Portfolio TIPS ETF